Product Description
| Cat Number | KS-200 |
|---|---|
| Category | Peptide |
| Pack Size | 1 mg |
| Description | AKAP-PKA interaction inhibitor |
| Modification | N-terminal stearyl |
| Purity | >95% by hplc |
| Biomarker Target | Protein-protein interactions,Kinases |
| Sequence Three Letter Code | Stearyl-Asp-Leu-Ile-Glu-Glu-Ala-Ala-Ser-Arg-Ile-Val-Asp-Ala-Val-Ile-Glu-Gln-Val-Lys-Ala-Ala-Gly-Ala-Tyr-OH |
| Molecular Formula | C129H217N29O39 |
| Sl Sequence | Stearyl-DLIEEAASRIVDAVIEQVKAAGAY |
| Solubility | Soluble to 1 mg/ml in 0.01M PBS |
| Appearance | Freeze dried solid |
| Storage | Store dry, frozen and in the dark |
| References |
Carr (1992) Association of the type II cAMP-dependent protein kinase with a human thyroid RII-anchoring protein. Cloning and characterization of the RII-binding domain. J Biol Chem. 267(19) 13376 PMID: 1618839Ma et al (2011) Ht31, a protein kinase A anchoring inhibitor, induces robust cholesterol efflux and reverses macrophage foam cell formation through ATP-binding cassette transporter A1. J Biol Chem. 286(5) 3370 PMID: 21106522Baarsma et al (2020) Disruption of AKAP-PKA Interaction Induces Hypercontractility With Concomitant Increase in Proliferation Markers in Human Airway Smooth Muscle. Front Cell Dev Biol. 8 165 PMID: 32328490 Related areasAll cell penetrating peptides >All protein-protein interaction modulators > |
| Note | The product is for research use only |
Share Item: